LCTC Lifeloc Technologies, Inc
Laboratory Analytical Instruments · OTC · SEC CIK 1493137 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY10.0%
TTM net income YoY-49.9%
TTM EPS YoY-50.0%
Revenue 3-yr CAGR1.0%
Net income 3-yr CAGR—
Margins
Gross margin42.7%
Operating margin-6.5%
Net margin-19.9%
FCF margin-3.8%
EBITDA margin-3.0%
Returns
ROE-40.5%
ROA-24.7%
ROIC (approx.)-9.9%
Asset turnover1.25x
Leverage & solvency
Liabilities / assets46.7%
Debt / equity0.27x
Current ratio3.95x
Interest coverage-4.24x
Cash quality & payout
Operating cash flow / net income-0.03x
Accruals ratio-25.6%
Payout ratio—
Capex / revenue4.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $2.52M | $2.44M | $2.29M | $2.27M | $2.26M | $2.22M | $2.28M | $1.91M |
| Cost of revenue | $1.43M | $1.35M | $1.31M | $1.37M | $1.35M | $1.29M | $1.37M | $1.20M |
| Gross profit | $1.09M | $1.09M | $987,074 | $902,187 | $906,693 | $924,599 | $908,566 | $705,244 |
| R&D expense | $505,982 | $560,281 | $414,445 | $601,154 | $458,747 | $623,262 | $469,680 | $503,887 |
| SG&A expense | $319,223 | $314,853 | $387,402 | $322,503 | $340,705 | $340,074 | $384,878 | $305,852 |
| Operating income | -$50,071 | -$103,576 | -$128,002 | -$336,881 | -$234,326 | -$378,265 | -$280,548 | -$422,607 |
| Interest expense | $43,594 | $39,610 | $31,242 | $31,437 | $36,953 | $26,305 | $24,495 | $9,919 |
| Pretax income | -$84,931 | — | — | — | -$263,439 | -$393,639 | -$292,686 | — |
| Income tax | $0 | $0 | $0 | $1.16M | $0 | $0 | $0 | -$112,706 |
| Net income | -$84,931 | -$134,330 | -$152,713 | -$1.52M | -$263,439 | -$393,639 | -$292,686 | -$312,827 |
| EBITDA | $27,100 | -$35,387 | -$60,229 | -$218,522 | -$125,650 | -$269,423 | -$178,142 | -$317,410 |
| EPS (basic) | -0.03 | -0.05 | -0.06 | — | -0.10 | -0.14 | -0.11 | — |
| EPS (diluted) | -0.03 | -0.05 | -0.06 | — | -0.10 | -0.14 | -0.11 | — |
| Weighted avg. shares (diluted) | 2.75M | 2.75M | 2.75M | — | 2.75M | 2.75M | 2.69M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $930,539 | $908,208 | $569,330 | $746,001 | $685,097 | $995,750 | $1.52M | $1.24M |
| Receivables | $785,442 | $826,715 | $850,341 | $772,380 | $864,456 | $765,730 | $761,697 | $732,541 |
| Inventory | $2.68M | $2.84M | $2.79M | $2.63M | $2.86M | $2.99M | $2.94M | $3.00M |
| Current assets | $4.55M | $4.78M | $4.37M | $4.27M | $4.61M | $4.97M | $5.68M | $5.09M |
| PP&E, net | $2.31M | $2.19M | $2.25M | $2.30M | $2.41M | $2.41M | $2.29M | $2.38M |
| Intangibles | $65,324 | $67,229 | $69,134 | $71,039 | $73,008 | $74,913 | $76,818 | $78,723 |
| Total assets | $7.00M | $7.08M | $6.74M | $6.69M | $8.30M | $8.62M | $9.22M | $8.72M |
| Current liabilities | $1.15M | $1.10M | $1.06M | $836,870 | $907,861 | $956,094 | $1.13M | $743,575 |
| Short-term debt | — | — | — | — | $54,431 | $54,016 | $53,604 | $53,195 |
| Long-term debt | $1.02M | $1.03M | $1.04M | $1.06M | $1.07M | $1.09M | $1.10M | $1.12M |
| Total debt | $1.02M | $1.03M | $1.04M | $1.06M | $1.13M | $1.14M | $1.15M | $1.17M |
| Total liabilities | $3.27M | $3.26M | $2.79M | $2.58M | $2.68M | $2.74M | $2.94M | $2.50M |
| Shareholders' equity | $3.73M | $3.82M | $3.95M | $4.10M | $5.62M | $5.89M | $6.28M | $6.23M |
| Net debt | $85,632 | $122,156 | $475,119 | $312,425 | $441,631 | $144,328 | -$369,131 | -$71,399 |
| Shares outstanding | 2.75M | 2.75M | 2.75M | 2.75M | 2.75M | 2.75M | 2.75M | 2.66M |
| Cash flow statement | ||||||||
| Operating cash flow | $247,959 | -$133,212 | -$129,365 | $79,118 | -$188,861 | -$289,219 | -$100,357 | -$291,791 |
| Capital expenditure | $0 | $0 | $5,370 | $423,283 | $16,700 | $22,810 | $0 | $62,108 |
| Free cash flow | $247,959 | -$133,212 | -$134,735 | -$344,165 | -$205,561 | -$312,029 | -$100,357 | -$353,899 |
| Investing cash flow | -$197,330 | $0 | -$19,781 | -$4,225 | -$107,905 | -$223,703 | -$18,548 | -$42,500 |
| Financing cash flow | -$28,298 | $472,090 | -$27,525 | -$13,989 | -$13,887 | -$13,785 | $397,616 | $736,416 |
| Depreciation & amortization | $77,171 | $68,189 | $67,773 | $118,359 | $108,676 | $108,842 | $102,406 | $105,197 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.